# Power Pitch Session III: CEST Methods & Applications

**You can click on the links to reach the GitHub discussion pages of the individual talks.**

## Date & Time

Tuesday, 18.09.2024: 11:30 - 12:00

## Moderators

* Jan-Rüdiger Schüre

* Daniel Paech

## Power Pitches

* [Differentiating Tumor Progression from Radionecrosis using Fluid-Suppressed APTw Imaging](https://github.com/cest-sources/CEST-conference-2024/discussions/100)
* [Tracking Age-Related Changes using NOEMTR in Brain Subregions at 3T](https://github.com/cest-sources/CEST-conference-2024/discussions/7)
* [Can CEST be used as an aging biomarker?](https://github.com/cest-sources/CEST-conference-2024/discussions/12)
* [Breathing life into renal CEST-imaging: A feasibility study on retrospective gating in renal CEST imaging](https://github.com/cest-sources/CEST-conference-2024/discussions/26)
* [In vitro CEST-based pH in muscle (patho)physiological range at 3T](https://github.com/cest-sources/CEST-conference-2024/discussions/31)
* [PET-MR compatible CEST method for imaging of Alzheimer’s Disease](https://github.com/cest-sources/CEST-conference-2024/discussions/33)
* [Multicenter Validation of Amide Proton Transfer Weighted Imaging for the Classification of Adult-type Diffuse Gliomas](https://github.com/cest-sources/CEST-conference-2024/discussions/35)
* [Assessing metabolic heterogeneity and invasion patterns in glioma recurrence by APTw CEST MRI](https://github.com/cest-sources/CEST-conference-2024/discussions/37)
* [Differentiation between glioblastoma and solitary brain metastases using APTw and perfusion MRI](https://github.com/cest-sources/CEST-conference-2024/discussions/40)
* [Differentiation of pseudoprogression and tumor recurrence of glioblastoma using amide proton transfer (APT) imaging at 3 Tesla](https://github.com/cest-sources/CEST-conference-2024/discussions/45)
* [cCEST in Multiple Sclerosis at 7T: Investigating the potential to distinguish “unspecific” and “MS” white matter lesions](https://github.com/cest-sources/CEST-conference-2024/discussions/54)
* [Insights into CEST in Human Ischemic Stroke at 7T: Results of different evaluation approaches](https://github.com/cest-sources/CEST-conference-2024/discussions/57)
* [Assessing Gamma-Knife Treatment Response in Human Brain Metastasis with CEST MRI](https://github.com/cest-sources/CEST-conference-2024/discussions/59)
* [Investigating MRI-CEST tumor pH imaging to assess prostate cancer aggressiveness](https://github.com/cest-sources/CEST-conference-2024/discussions/62)
* [glycoNOE signals in a mouse model of Parkinson’s disease](https://github.com/cest-sources/CEST-conference-2024/discussions/65)
* [Hierarchical Multi-task Transformer for tumor segmentation and response assessment in patients with malignant gliomas via structural and amide proton transfer-weighted MRI](https://github.com/cest-sources/CEST-conference-2024/discussions/88)
* [I can see clearly now the fluids are gone – 3T APTw CEST with fluid suppression in different brain tumors](https://github.com/cest-sources/CEST-conference-2024/discussions/94)
